Contrasting Effects of D‐ and L‐(E)‐4‐(3‐Phospiono‐2‐ Propenyl) Piperazine‐2‐Carboxylic Acid as Anticonvulsants and as Inhibitors of Potassium‐Evoked Increases in Hippocampal Extracellular Glutamate and Aspartate Levels in Freely Moving Rats I
- 1 January 1994
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 62 (1), 217-222
- https://doi.org/10.1046/j.1471-4159.1994.62010217.x
Abstract
Microdialysis experiments performed in the dorsal hippocampus of freely moving rats showed that L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid (L-CPPene) is 10 times as potent as D-CPPene in inhibiting potassium-induced increases in extracellular levels of aspartate and glutamate. In control experiments, two 100 mM KCl stimuli (S1 and S2) applied for 10 min each (separated by a 40-min recovery period) produced substantial (300-500%) increases in the extracellular levels of aspartate, glutamate, taurine, and GABA and a 50% decrease in the glutamine level. S2/S1 ratios in the control groups were 0.67 (aspartate), 0.78 (glutamate), 0.83 (GABA), and 0.85 (taurine). In the experimental groups, D- or L-CPPene was applied via the probe during the second potassium stimulus (S2). L-CPPene (25 or 250 microM) produced selective suppression of potassium-induced increases of extracellular glutamate (S2/S1 ratio: 0.25) and aspartate (S2/S1 ratio: 0.20) levels, whereas 250 microM D-CPPene was required to inhibit the extracellular aspartate and glutamate increases. Neither enantiomer of CPPene affected the potassium-induced increases of GABA and taurine or the decrease in extracellular glutamine concentration. An additional study comparing the anticonvulsant potencies of D- and L-CPPene was performed using audiogenic DBA/2 mice. The anticonvulsant potency of D-CPPene, as assessed against sound-induced seizures in DBA/2 mice, was an order of magnitude higher than that of L-CPPene [ED50 clonic phase (intraperitoneal, 45 min): 1.64 mumol/kg and 16.8 mumol/kg, respectively]. We attribute the anticonvulsant action of D-CPPene to its antagonist action at the NMDA receptor.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 29 references indexed in Scilit:
- Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brainThe Lancet, 1993
- Seizure related elevations of extracellular amino acids in human focal epilepsyNeuroscience Letters, 1992
- Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone ratsEuropean Journal of Pharmacology, 1992
- Potent oral anticonvulsant action of CPP and CPPene in DBA/2 miceEuropean Journal of Pharmacology, 1990
- Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4‐(3‐phosphonopropyl)piperazine‐2‐carboxylic acid (CPP) and of the unsaturated analogue (E)‐4‐(3‐phosphonoprop‐2‐enyl)piperazine‐2‐carboxylic acid (CPP‐ene)Helvetica Chimica Acta, 1989
- Possible presynaptic actions of 2-amino-4-phosphonobutyrate in rat olfactory cortexBritish Journal of Pharmacology, 1987
- The action of some analogues of the excitatory amino acids in the dentate gyrus of the ratCanadian Journal of Physiology and Pharmacology, 1984
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cordBrain Research, 1982
- Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of γ-aminobutyric acid (GABA) in mice with audiogenic seizuresBiochemical Pharmacology, 1976